In a sector note on U.S. Medical Supplies and Devices, UBS analyst Danielle Antalffy initiated coverage of Boston Scientific with a Buy rating and $57 price target.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on BSX:
- TD Cowen medical devices analyst to hold analyst/industry conference call
- Wells downgrades Edwards Lifesciences with Medtronic gaining share
- Boston Scientific price target raised to $55 from $50 at Argus
- Boston Scientific price target raised to $53 from $48 at Needham
- Boston Scientific price target raised to $52 from $50 at Stifel